BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 22, 2021
View Archived Issues
New CRISPR-Cas vector designs reduce vector size and increase vector titer for HIV/AIDS treatment
Read More
Studies show NNRTI MK-8507 can be used with islatravir, levonorgestrel/ethinyl estradiol
Read More
FDA approves IND for phase I/II study of Zofin in COVID-19 long haulers
Read More
FDA clears IND for Viracta's all-oral combination regimen in EBV-positive solid tumors
Read More
Positive data reported from phase Ib study of IMT-002 in T1D with HLA-DQ8 trait
Read More
Medshine Discovery patents new KHK inhibitors for NASH
Read More
Sorrento initiates dosing in U.K. phase II study of COVI-DROPS in outpatient setting
Read More
Positive phase II data for eprenetapopt plus azacitidine in TP53 mutant MDS and AML
Read More
IRF7 and PTDSS2 are therapeutic targets in HIV-1 infection
Read More
IFM Due divulges hSTING antagonists
Read More
Tyra Biosciences presents new FGFR inhibitors
Read More
R-107 shows the ability to prevent, treat and reverse established PAH in vivo
Read More
Rheos Medicines discloses MALT1 inhibitors
Read More
Apoptosis inhibitors show promise in severe TB models
Read More
Eureka initiates phase I/II ARYA-3 study of ECT-204 in liver cancer
Read More
Dicerna provides interim data from phase I study of belcesiran in AATLD
Read More
XPB shown to regulate HIV-1 transcriptional activity
Read More
Antengene obtains HREC approval in Australia for phase I study of ATG-101 in solid tumors and NHL
Read More
Addition of CF-296 to SOC leads to enhanced antibacterial activity against MSSA and MRSA isolates
Read More
Amplia reports phase I data on AMP-945
Read More
